RxDoctor Payments Data

Stacy Cwach

Physician Assistant · Pierre, SDNPI 1790233591

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,492in general payments, 2019–2025

Across 221 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$717
  • Amgen$493
  • Pfizer$402
  • E.r. Squibb & Sons, L.L.C.$346
  • Novo Nordisk$261
  • Boehringer Ingelheim$166
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,492100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,492 in reported general payments places this provider in the 90th percentile of 548 physician assistant providers in South Dakota.

See all physician assistant providers in South Dakota

Medicare billing

Part B allowed, 2024
$50,865
Medicare patients
258
Services billed
646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban44$34,734
JardianceEmpagliflozin34$30,643
OzempicSemaglutide26$25,961
MounjaroTirzepatide20$19,720
Atorvastatin Calcium157$1,511
Memantine Hcl14$1,404
Estradiol12$1,314
Levothyroxine Sodium126$1,182
Potassium Chloride60$1,099
Ulticare Pen NeedlePen Needle, Diabetic12$990
SynthroidLevothyroxine Sodium11$979
Gabapentin13$935
Pantoprazole Sodium74$887
Pregabalin21$830
Duloxetine Hcl40$729

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$402$34,73444 claims
Boehringer IngelheimJardiance$166$30,64334 claims
Novo NordiskOzempic$261$25,96126 claims
Lilly USA, LLCMounjaro$717$19,72020 claims
AbbVieSynthroid$63$97911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 548 physician assistant providers in South Dakota.

Other physician assistant in Pierre

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →